For the quarter ending 2025-09-30, HCWB made $15,606 in revenue. -$4,554,336 in net income. Net profit margin of -29183.24%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenues | 15,606 | 6,550 | 5,065 | 641,698 |
| Cost of revenues | 12,485 | 5,240 | 4,052 | 401,847.25 |
| Net revenues | 3,121 | 1,310 | 1,013 | 239,850.75 |
| Research and development | 1,404,247 | 1,226,824 | 1,478,711 | 1,597,248.5 |
| Legal expenses, net | - | - | -1,739,493 | 3,977,620 |
| General and administrative | 1,884,994 | 2,096,021 | 2,227,597 | 1,709,899 |
| Legal expenses (recoveries), net | 6,006 | 142,542 | - | - |
| Reserve for credit losses and other expenses | - | - | - | 325,000 |
| Nonoperating loss | 0 | 0 | - | - |
| Total operating expenses | 3,295,247 | 3,465,387 | 1,966,815 | 7,609,767.5 |
| Loss from operations | -3,292,126 | -3,464,077 | -1,965,802 | -7,369,916.75 |
| Interest expense | 127,070 | 228,714 | 255,822 | 157,784.25 |
| Change in fair value of investment and contingent liability, net | -966,284 | - | - | - |
| Unrealized gain on investment | - | 1,748,688 | - | - |
| Loss on sale of put shares | -182,146 | - | - | - |
| Other income, net | 13,290 | 16,373 | 24,749 | 21,747.5 |
| Net loss | -4,554,336 | -1,927,730 | -2,196,875 | -7,505,953.5 |
| Equity dividend to investor | 0 | 10,153,799 | - | - |
| Net loss attributable to common stockholders | -4,554,336 | -12,081,529 | - | - |
| Earnings per share, basic | -2.02 | -6.79 | -0.05 | -0.193 |
| Earnings per share, diluted | -2.02 | -6.79 | -0.05 | -0.193 |
| Weighted average number of shares outstanding, basic | 2,260,068 | 1,780,113 | 44,675,656 | 9,698,254.5 |
| Weighted average number of shares outstanding, diluted | 2,260,068 | 1,780,113 | 44,675,656 | 9,698,254.5 |
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)